当前位置: 首页 >> 检索结果
共有 62138 条符合本次的查询结果, 用时 2.5476616 秒

61. Performance of Creatinine and Cystatin C-Based Equations to Estimate Glomerular Filtration Rate Among Patients With Heart Failure.

作者: John Roth.;John C Lieske.;Sandra M Herrmann.;A M Arruda-Olson.;Joerg Herrmann.;Wendy McCallum.;Timothy S Larson.;Andrew D Rule.;Silvia M Titan.
来源: Circ Heart Fail. 2025年e013014页
The performance of estimated glomerular filtration rate (eGFR) among patients with heart failure (HF) may be worse than in the general population due to a higher prevalence of confounding factors affecting creatinine and cystatin C. Studies in this area are scarce and not stratified by type of HF. We evaluated the performance of current creatinine and cystatin C equations (eGFR creatinine-based equation [eGFRcr], eGFR serum cystatin C-based, and eGFR creatinine-cystatin C equation) compared with measured GFR (mGFR) among patients with HF stratified by ejection fraction.

62. Procedural and Clinical Outcomes After Orbital Atherectomy Versus Intravascular Lithotripsy in Patients With Calcified Nodules.

作者: Ali H Dakroub.;Doosup Shin.;Mandeep Singh.;Sarah Malik.;Rick H J A Volleberg.;Jonathan Weber.;Yasemin Ciftcikal.;Alysse Fazal.;Koshiro Sakai.;Takao Sato.;Akiko Maehara.;Mitsuaki Matsumura.;Jeffrey W Moses.;Gary S Mintz.;Omar Khalique.;Fernando Sosa.;Evan Shlofmitz.;Allen Jeremias.;Richard A Shlofmitz.;Ziad A Ali.
来源: Circ Cardiovasc Interv. 2025年e015254页
Calcified nodules (CNs) remain a major challenge in percutaneous coronary intervention (PCI). We sought to compare procedural and clinical outcomes after orbital atherectomy (OA) versus intravascular lithotripsy (IVL)-facilitated PCI in patients with CNs.

63. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

作者: Daniel W Jones.;Keith C Ferdinand.;Sandra J Taler.;Heather M Johnson.;Daichi Shimbo.;Marwah Abdalla.;M Martine Altieri.;Nisha Bansal.;Natalie A Bello.;Adam P Bress.;Jocelyn Carter.;Jordana B Cohen.;Karen J Collins.;Yvonne Commodore-Mensah.;Leslie L Davis.;Brent Egan.;Sadiya S Khan.;Donald M Lloyd-Jones.;Bernadette Mazurek Melnyk.;Eva A Mistry.;Modele O Ogunniyi.;Stacey L Schott.;Sidney C Smith.;Amy W Talbot.;Wanpen Vongpatanasin.;Karol E Watson.;Paul K Whelton.;Jeff D Williamson.
来源: Circulation. 2025年
The "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults" retires and replaces the "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults."

64. A Trans-Atlantic Perspective on the 2025 AHA/ACC Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

作者: Michel Azizi.;Stephen P Juraschek.
来源: Circulation. 2025年

65. Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy.

作者: Zhen Guo.;Anahita Ataran.;Pan Ma.;Wenjing Yu.;Hamidreza Hajirezaei.;Carla Valenzuela Ripoll.;Lauren Pedersen.;Omid Rashidi.;Mandy M Chan.;Mengcheng Shen.;Shannon Kelley.;Alireza Sargazi.;Mualla Ozcan.;Aynaz Lotfinaghsh.;Yoonje Cho.;Ahmed Diab.;Felicia Grogan.;Amanda Klaas.;Alexander Pompian.;Adnan Imam.;Rehman Lodhi.;Amen Bekele Zelleke.;Attila Kovacs.;Kenneth B Margulies.;Jeff Szymanski.;Marco Sardiello.;Babak Razani.;Aarti Asnani.;Benjamin Kopecky.;Pierre E Signore.;B Alexander Yi.;Craig T Basson.;Kodi S Ravichandran.;Sumanth D Prabhu.;Carmen Bergom.;Joel D Schilling.;Kory J Lavine.;Ali Javaheri.
来源: Circulation. 2025年
Doxorubicin cardiomyopathy (DoxCM) remains a significant clinical problem, but its underlying mechanisms remain incompletely understood. Identifying DoxCM mechanisms can lead to therapeutic interventions that improve patient outcomes.

66. TBX5 and CHD4 Coordinately Activate Atrial Cardiomyocyte Genes to Maintain Cardiac Rhythm Homeostasis.

作者: Mason E Sweat.;Wei Shi.;Yan Y Sweat.;Jie Li.;Jiajin Li.;Erin M Keating.;Anna Ponek.;Qing Ma.;Chaehyoung Park.;Michael A Trembley.;Yi Wang.;Cuilan Hou.;Vassilios J Bezzerides.;Frank L Conlon.;William T Pu.
来源: Circulation. 2025年
Atrial fibrillation, the most common sustained arrhythmia, affects 59 million individuals worldwide. The transcription factor TBX5 (T-box 5) is essential for normal atrial rhythm. Its inactivation causes loss of atrial cardiomyocyte (aCM) enhancer accessibility, looping, transcriptional identity, and spontaneous atrial fibrillation. TBX5 interacts with CHD4 (chromodomain helicase DNA-binding protein 4), a chromatin remodeling ATPase canonically associated with the NuRD (nucleosome remodeling and deacetylase) repressor complex.

67. Simultaneous or Rapid Sequence Optimization of Medical Therapy for Heart Failure: Time to Keep Score.

作者: Satoshi Shoji.;Gregg C Fonarow.;Stephen J Greene.
来源: Circ Heart Fail. 2025年e013417页

68. Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis.

作者: Sung-Ji Park.;Mijin Kim.;Jihee Son.;Ha Hye Jo.;Ga Yun Kim.;Jihoon Kim.;Byung Joo Sun.;Eun-Kyung Kim.;Sahmin Lee.;Jae Suk Yoo.;Sung-Cheol Yun.;Sung-Ho Jung.;Jong-Min Song.;Duk-Hyun Kang.
来源: Circulation. 2025年
The timing of surgery in asymptomatic severe mitral regurgitation remains controversial. This observational study sought to compare long-term outcomes of early surgery with a conventional treatment strategy in asymptomatic patients with severe mitral regurgitation.

69. Up in Smoke: No Association Between Cannabis Smoking and Cardiovascular Events Among Older Military Veterans With Coronary Artery Disease.

作者: Denise C Vidot.
来源: Circulation. 2025年152卷6期366-368页

70. Intramyocardial Hemorrhage After Myocardial Infarction: A Prognostic Outcome for Clinical Practice and Trials.

作者: Colin Berry.;Jaclyn Carberry.;Rohan Dharmakumar.
来源: Circulation. 2025年152卷6期349-351页

71. Letter by Kornelius Regarding Article, "Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure".

作者: Edy Kornelius.
来源: Circulation. 2025年152卷6期e63页

72. Novel Human Heart-Derived Natural Adeno-Associated Virus Capsid Combines Cardiospecificity With Cardiotropism In Vivo.

作者: Daniel Zeissler.;Martin Busch.;Sebastian Grieskamp.;Eric Meinhardt.;Hanna Wurzer.;Shubhada R Kulkarni.;Anna K Schrattel.;Stephanie Molter.;Dorothea Kehr.;Maria Qatato.;Christoph Rummel.;Arne Hansen.;Malte Loos.;Kinga M Wrona.;Mirko Völkers.;Vivien Kmietczyk.;Julia Wingert.;Viet Loan Dao Thi.;Jungen Hu.;Philipp Schlegel.;Christoph Dieterich.;Hugo A Katus.;Norbert Frey.;Andreas Jungmann.;Julia Ritterhoff.;Patrick Most.
来源: Circulation. 2025年152卷6期416-419页

73. Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II.

作者: Rebecca B Lawn.;Audrey R Murchland.;Rebecca C Thurston.;Camille Marquez.;Karen Jakubowski.;Laura Sampson.;Jennifer A Sumner.;Laura D Kubzansky.;Karestan C Koenen.
来源: Circulation. 2025年
Stalking is one of the most common forms of interpersonal violence, with nearly 1 in 3 women experiencing it in their lifetime. Restraining orders are a legal remedy aimed at protecting women who experience the most severe forms of stalking and interpersonal violence. Previous work has shown associations between experiences of violence and cardiovascular health among women, but little is known about the link between being stalked or obtaining a restraining order and risk of cardiovascular disease (CVD).

74. Ultraprocessed Foods and Their Association With Cardiometabolic Health: Evidence, Gaps, and Opportunities: A Science Advisory From the American Heart Association.

作者: Maya K Vadiveloo.;Christopher D Gardner.;Sara N Bleich.;Neha Khandpur.;Alice H Lichtenstein.;Jennifer J Otten.;Casey M Rebholz.;Chelsea R Singleton.;Miriam B Vos.;Selina Wang.; .
来源: Circulation. 2025年
Ultraprocessed foods and beverages (UPFs) pose a growing public health challenge. Commonly defined by the Nova system, UPFs are industrially processed products made with additives or ingredients not commonly used in home cooking. Although ultraprocessing or extensive processing can lower cost and improve shelf life, convenience, and taste of certain products, high UPF intake is consistently linked to negative health outcomes. Although mechanisms remain unclear, evidence supports food policies that limit UPF intake while avoiding unintended consequences. Identifying high-risk UPF subgroups is essential to balancing nutritional goals with the need for accessible and appealing food options. Most UPFs overlap with foods high in saturated fat, added sugars, and sodium, which are already targets for cardiometabolic risk reduction. Future priorities include uncovering how UPFs specifically affect cardiometabolic health, refining dietary guidance to discourage nutrient-poor UPFs, and clarifying the impact of UPFs with more favorable profiles. This science advisory reviews current evidence on UPFs and their impact on cardiometabolic health and outlines research needs, regulatory reform, and policy changes needed to affect better dietary intake and overall health.

75. AI and Digital Health: Personalizing Physical Activity to Improve Population Health.

作者: Daniel Seung Kim.;Fatima Rodriguez.;Euan A Ashley.
来源: Circ Cardiovasc Qual Outcomes. 2025年e012416页

76. G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice.

作者: Pan Gao.;Mengying Cao.;Xiaolin Wang.;Hongyuan Zhang.;Xuanlong Chen.;Ziyan Song.;Molin Zhang.;Lin Li.;Chao Yin.;Jie Yuan.;Shen Cai.;Zening Wang.;Zhonglian Cao.;Chen Su.;Guoping Zhang.;Issei Komuro.;Junbo Ge.;Liliang Li.;Yunzeng Zou.
来源: Circulation. 2025年
GRKs (GPCR [G protein-coupled receptor] kinases) are key regulators of GPCR signaling. Because GPCRs are targeted by approximately 40% of clinical drugs, GRKs also represent therapeutic targets for combating cardiovascular diseases. However, the predominant GRK that responds to diabetic heart injury and the underlying mechanisms remain largely unknown.

77. Prognostic Value of PET-Derived Myocardial Flow Reserve in Patients With Very High Coronary Artery Calcium Score.

作者: Mahmoud Al Rifai.;Maria Alwan.;Ahmed Ibrahim Ahmed.;Talal Alnabelsi.;Ahmed Aljizeeri.;Mouaz H Al-Mallah.
来源: Circ Cardiovasc Imaging. 2025年e018361页
Coronary artery calcium (CAC) is a strong predictor of cardiovascular outcomes, with patients having high CAC experiencing event rates similar to those in secondary prevention populations. Emerging evidence suggests that patients with extremely high CAC (≥1000) represent a distinct high-risk group. Therefore, this study aims to evaluate the prognostic value of myocardial flow reserve (MFR) in patients with very high CAC.

78. Response by Ulacia Flores and Bertrand to Letter Regarding Article, "Randomized Study Comparing Angiography Guidance With Physiology Guidance After PCI: The EASY-PREDICT Study".

作者: Paola Ulacia Flores.;Olivier F Bertrand.
来源: Circ Cardiovasc Interv. 2025年e015633页

79. Progression of Bioprosthetic Aortic Valve Calcification and Clinical Outcome.

作者: Ziang Li.;Bin Zhang.;Erwan Salaun.;Nancy Côté.;Philippe Pibarot.;Yongjian Wu.;Marie-Annick Clavel.
来源: Circ Cardiovasc Imaging. 2025年e018036页

80. Role of Passive Leg Raise Stress Echocardiography in Latent Stiff Left Atrial Syndrome.

作者: Michito Murayama.;Hiroyuki Iwano.;Satonori Tsuneta.;Noriyuki Otsuka.;Makoto Kambayashi.;Yui Shimono.;Yoji Tamaki.;Suguru Ishizaka.;Shinobu Yokoyama.;Hisao Nishino.;Sanae Kaga.;Toshiyuki Nagai.;Toshihisa Anzai.
来源: Circ Cardiovasc Imaging. 2025年e018662页
共有 62138 条符合本次的查询结果, 用时 2.5476616 秒